Budesonide Press Articles

Business Wire - Santarus Announces Presentation of New Open-Label UCERIS (Budesonide) Data at the Crohn’s and Colitis Foundation Clinical & Research Conference

December 1, 2011 --

continue reading

Business Wire - Santarus Submits New Drug Application to FDA for UCERIS (budesonide) Tablets

December 1, 2011 --

continue reading

Drug Store News - Asthma: diabetes comorbidity discovered

November 14, 2011 --

According to a study published in September in the journal Pediatrics, there appears to be a significant number of children with diabetes who...

continue reading

Business Wire - Santarus Reports Third Quarter 2011 Financial Results

November 7, 2011 --

Total revenues up 48% over prior year period

Full year net income...

continue reading

Business Wire - Santarus Announces Presentation of Pooled Data from Budesonide MMX Phase III Clinical Studies at the ACG Annual Scientific Meeting

November 1, 2011 --

Receives conditional FDA acceptance of trade name UCERIS

continue reading

Business Wire - Santarus Announces Supportive Top-Line Results from Budesonide MMX Extended Use Study

September 20, 2011 --

Submission of NDA for induction of remission of ulcerative colitis planned for December 2011

...

continue reading

Chain Drug Review - Top 20 generic drugs by U.S. sales

August 29, 2011 --

Top 20 Generic Drugs by U.S. SalesRank   Product                          2010 dollar sales (mil.)1      Pantoprazole Sodium...

continue reading

Business Wire - Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

May 16, 2011 -- HASH(0x13ea12e0)

DENVER -- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing...

continue reading

Business Wire - Santarus Announces Oral Presentations of Budesonide MMX Phase III Data at Digestive Disease Week Meeting

May 3, 2011 -- HASH(0x1e3e9530)

SAN DIEGO -- Santarus, Inc. (NASDAQ: SNTS) today announced that the budesonide MMX® Phase...

continue reading

Internal Medicine News - Budesonide noninferior to mesalamine in Crohn's

March 1, 2011 --

Budesonide was found noninferior to, but not better than, mesalamine for inducing remission of mildly to moderately active Crohn's disease in...

continue reading


Our Services

Do not forget to check the lastest products and auctions related to Budesonide as well as our free videos and podcasts.

best Budesonide products current Budesonide auctions current Budesonide videos listen to Budesonide podcasts

This Day In History

Latest Posts